@prefix dcterms: <
http://purl.org/dc/terms/
> .
@prefix ns1: <
http://www.w3.org/ns/prov#
> .
@prefix this: <
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
> .
@prefix sub: <
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#
> .
@prefix schema: <
https://schema.org/
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix nt: <
https://w3id.org/np/o/ntemplate/
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix orcid: <
https://orcid.org/
> .
@prefix bl: <
https://w3id.org/biolink/vocab/
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
<
http://purl.obolibrary.org/obo/DOID_289
>
bl:category
bl:Disease
.
sub:association
rdf:object
<
http://purl.obolibrary.org/obo/DOID_289
> ;
rdf:predicate
bl:treats
;
rdf:subject
<
https://identifiers.org/drugbank:DB00717
> ;
a
rdf:Statement
;
rdfs:label
"aygestin norethindrone acetate tablets usp is indicated for the treatment of secondary amenorrhea endometriosis and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology such as submucous fibroids or uterine cancer aygestin norethindrone acetate tablets usp is not intended recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for endometrial protection" ;
bl:association_type
bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation
;
bl:provided_by
<
https://w3id.org/um/NeuroDKG
> ;
bl:relation
schema:TreatmentIndication
.
<
https://identifiers.org/drugbank:DB00717
>
bl:category
bl:Drug
.
}
sub:provenance
{
sub:assertion
ns1:wasAttributedTo
orcid:0000-0002-1468-3557
.
}
sub:pubinfo
{
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
npx:hasSignature
"H0VeovxusxThqRp1pbnlm62fLTBPz1F0L+C6P+HD9eiYgzwG8EY2bPQ/x5OPNtbz4AmVyua86Ss39eEg/3qNZetO4V0AXTA6GmQ1B4PTkbDNWbNZXqz3FQRFzjXbHikOYyhKJ9uWdB0t/gw5UMJ5ppFczSR3iwzCITqB4l8D360=" ;
npx:hasSignatureTarget
this:
.
this:
dcterms:created
"2021-07-03T11:41:55.828+02:00"^^
xsd:dateTime
;
dcterms:creator
orcid:0000-0002-1468-3557
;
nt:wasCreatedFromProvenanceTemplate
<
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
> ;
nt:wasCreatedFromPubinfoTemplate
<
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
> ;
nt:wasCreatedFromTemplate
<
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs
> .
}